Home › NDC Lookup › RxCUI directory › RxCUI 656742

Potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasi... — RxCUI 656742

RxNorm drug concept · Semantic branded drug
RxCUI 656742 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI656742
Official namePotassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG Oral Tablet [Phospha 250 Neutral]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asK+ phosphate 155 MG / Sodium Phosphate, Dibasic 852 MG / Sodium Phosphate, Monobasic 130 MG Oral Tablet [Phospha 250 Neutral]; Phospha 250 Neutral 852 MG / 155 MG / 130 MG Oral Tablet; Pot phosphate 155 MG / Sodium Phosphate, Dibasic 852 MG / Sodium Phosphate, Monobasic 130 MG Oral Tablet [Phospha 250 Neutral]
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Potassium Phosphates: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. This IV form is used when your phosphate levels are too low to safely wait for a pill to work, or when you're not able to eat or take anything by mouth right now. I...
  • Why am I getting this through an IV instead of just taking a phosphorus pill?
  • It depends on how serious your kidney issues are. If you have severe kidney disease or are on dialysis, this specific product cannot be used — your kidneys would struggle to clear...
  • Is it safe to get this if I have kidney problems?
📖 Read our full Potassium Phosphates guide →

🕸️ Concept Web — How Potassium phosphate 155 MG / sodium phosphate, d... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG Oral Tablet [Phospha 250 Neutral] RxCUI 656742

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Potassium phosphate 34322
    • Sodium phosphate, dibasic 236719
    • Sodium phosphate, monobasic 235496
    • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic 1008010
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Phospha 250 Neutral 607414
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Oral Tablet 385063
    • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Oral Product 1165145
    • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Pill 1165146
    • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Oral Tablet [Phospha 250 Neutral] 656741
    • Phospha 250 Neutral Oral Product 1180637
    • Phospha 250 Neutral Pill 1180638
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG Oral Tablet SCD · 200251
  • Potassium phosphate 155 MG SCDC · 330758
  • Sodium phosphate, dibasic 852 MG SCDC · 336200
  • Sodium phosphate, monobasic 130 MG SCDC · 392925
  • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Oral Tablet SCDF · 385063
  • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Oral Product SCDG · 1165145
  • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Pill SCDG · 1165146

Brand-Name Concepts

  • Potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG [Phospha 250 Neutral] SBDC · 656740
  • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Oral Tablet [Phospha 250 Neutral] SBDF · 656741
  • Phospha 250 Neutral Oral Product SBDG · 1180637
  • Phospha 250 Neutral Pill SBDG · 1180638
  • Phospha 250 Neutral BN · 607414

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 656742 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64980-0729-01 100 TABLET in 1 BOTTLE (64980-729-01) PHOSPHA 250 NEUTRAL Rising Pharma Holdings, Inc. 2026-03-28
Observed labelers: Rising Pharma Holdings, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.